Z-Medica, LLC Establishes New Office in Boston
6/19/2013 10:13:39 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
BOSTON – June 19, 2013 – Z-Medica LLC, a leading developer and marketer of hemostatic agents, and the Massachusetts Life Sciences Center (MLSC) announced today that the company has opened a new office at 470 Atlantic Avenue in Boston, MA. The new office, which opened on May 1, 2013, enables Z-Medica to bring the company closer to one of the world’s most active regions for research to advance new therapies to control bleeding.
Z-Medica manufactures the QuikClot® family of hemostatic products. QuikClot is used to treat bleeding by healthcare professionals, law enforcement, first responders, adventure and outdoor sports enthusiasts, veterinarians, and consumers. QuikClot Combat Gauze® is the only hemostat recommended by the U.S. Department of Defense for all branches of the U.S. military for treatment of severe hemorrhage on the battlefield. This month Z-Medica launched a new line of products specifically designed to meet the unique needs of Emergency Medical Services.
“As our company continues to grow and develop new and more effective products to control bleeding, our presence in Boston will represent a great opportunity for us to join with worldwide leaders in life science and academic research who are developing therapies that require advanced hemostasis products,” said Larry Hicks, President and Chief Executive Officer at Z-Medica. “At the same time, our new office in Boston will allow us to meet the needs of all of our customers in the region with the highest possible levels of responsiveness and innovation.”
“In Massachusetts we invest in the life sciences because we are choosing to shape our own future,” said Governor Deval Patrick. “I welcome Z-Medica to our life sciences supercluster and look forward to the jobs and economic opportunities they will bring.”
Through the Massachusetts Life Sciences Center, Massachusetts is investing $1 billion over 10 years in the growth of the state’s life sciences supercluster. These investments are being made under the Massachusetts Life Sciences Initiative, proposed by Governor Patrick in 2007, and passed by the State Legislature and signed into law by Governor Patrick in 2008.
“On behalf of the team at the Massachusetts Life Sciences Center, I am excited to welcome Z-Medica to the Commonwealth,” said MLSC President & CEO Dr. Susan Windham-Bannister. “Z-Medica’s technology is changing how medical professionals approach wound care management in patients, enabling haemostasis, or the stoppage of bleeding, more quickly and efficiently. We look forward to supporting Z-Medica as its team puts down roots and grows in Massachusetts.”
QuikClot products are now in their third generation and are impregnated with a mineral called kaolin that has been clinically shown to accelerate the body’s natural coagulation cascade. Kaolin is a naturally-occurring, inert mineral that does not contain any botanicals, biological material, or shellfish products. It does not cause any exothermic reaction or vascular complications and there are no known complications. QuikClot products are credited with helping thousands of people survive traumatic blood loss events every year.
“Massachusetts also has a range of important incentives and support services designed to help innovative medical device and life science companies grow and succeed,” Hicks added. “We look forward to partnering with the MLSC and many other organizations in Massachusetts to develop new research and business opportunities for Z-Medica in the years ahead.”
“I’m excited to welcome the maker of such an important life-saving technology to Boston,” said Mayor Thomas M. Menino. “Z-Medica’s choice to come to our city where there is access to world-class hospitals and unparalleled workforce talent, will drive innovation in their field and grow their company.”
About Z-Medica® LLC
Z-Medica LLC is a medical device company founded in 2002 developing fast acting, easy to use, hemostasis products that stop bleeding wherever it occurs, making it possible to save lives and improve patient outcomes. The company manufactures and markets a portfolio of QuikClot® hemostasis products for use by healthcare professionals, first responders, law enforcement officers, consumers and the military.
Based on tests conducted by the Naval Medical Research Center and the U.S. Army Institute for Surgical Research, the Committee on Tactical Combat Casualty Care (CoTCCC) recommended QuikClot Combat Gauze® as the hemostatic agent for the Department of Defense and for use by all U.S. Military Forces as the first line treatment of traumatic bleeding. QuikClot® products are developed and manufactured in the United States. Z-Medica LLC is a privately-held company. For more information, visit www.z-medica.com
About the Massachusetts Life Sciences Center
The Massachusetts Life Sciences Center (MLSC) is a quasi-public agency of the Commonwealth of Massachusetts tasked with implementing the Massachusetts Life Sciences Act, a 10-year, $1-billion initiative that was signed into law in June of 2008. The MLSC’s mission is to create jobs in the life sciences and support vital scientific research that will improve the human condition. This work includes making financial investments in public and private institutions that are advancing life sciences research, development and commercialization as well as building ties among sectors of the Massachusetts life sciences community. For more information, visit www.masslifesciences.com
Help employers find you! Check out all the jobs and post your resume.
comments powered by